INTU vs STRO · P/E 64, rev $18.83B vs rev $62.0M
Intuit Inc (INTU) versus Sutro Biopharma (STRO) — a side-by-side from cached financials, not a winner call.
Intuit Inc (INTU) is a software - application company listed on US.
Sutro Biopharma (STRO) is a biotechnology company listed on NASDAQ.
Latest reported INTU revenue for 2025-07-31 was $18.83B. Net income was $3.87B. INTU currently screens at market cap $217.76B and trailing P/E 63.7.
Latest reported STRO revenue for 2024-12-31 was $62.0M. Net income was -$227.5M. Revenue was down 59.6% from 2023-12-31 to 2024-12-31. STRO currently screens at market cap $470.8M.
INTU currently screens at market cap $217.76B and trailing P/E 63.7. STRO currently screens at market cap $470.8M.
Not investment advice. Open the INTU and STRO stock pages for the full models.
Not investment advice.